RETRACTED: Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke
Authors:
- Yoshihiro SatoYSYoshihiro Sato
- Yoshiaki HondaYHYoshiaki Honda
- Jun IwamotoJIJun Iwamoto
- Tomohiro KanokoTKTomohiro Kanoko
- Kei SatohKSKei Satoh
- 2 March 2005
- journal article
- retracted article
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (9) , 1082-1088
Abstract
Context: Stroke increases the risk of subsequent hip fracture by 2 to 4 times. Hyperhomocysteinemia is a risk factor for both ischemic stroke and osteoporotic fractures in elderly men and women. Treatment with folate and mecobalamin (vitamin B 12 ) may improve hyperhomocysteinemia. Objective: To investigate whether treatment with folate and vitamin B 12 reduces the incidence of hip fractures in patients with hemiplegia following stroke. Design, Setting, and Patients: A double-blind, randomized controlled study of 628 consecutive patients aged 65 years or older with residual hemiplegia at least 1 year following first ischemic stroke, who were recruited from a single Japanese hospital from April 1, 2000, to May 31, 2001. Patients were assigned to daily oral treatment with 5 mg of folate and 1500 μg of mecobalamin, or double placebo; 559 completed the 2-year follow-up. Main Outcome Measure: Incidence of hip fractures in the 2 patient groups during the 2-year follow-up. Results: At baseline, patients in both groups had high levels of plasma homocysteine and low levels of serum cobalamin and serum folate. After 2 years, plasma homocysteine levels decreased by 38% in the treatment group and increased by 31% in the placebo group ( P < .001). The number of hip fractures per 1000 patient-years was 10 and 43 for the treatment and placebo groups, respectively ( P < .001). The adjusted relative risk, absolute risk reduction, and the number needed to treat for hip fractures in the treatment vs placebo groups were 0.20 (95% confidence interval [CI], 0.08-0.50), 7.1% (95% CI, 3.6%-10.8%), and 14 (95% CI, 9-28), respectively. No significant adverse effects were reported. Conclusion: In this Japanese population with a high baseline fracture risk, combined treatment with folate and vitamin B 12 is safe and effective in reducing the risk of a hip fracture in elderly patients following stroke.Keywords
This publication has 36 references indexed in Scilit:
- Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patientsArchives of orthopaedic and trauma surgery, 2003
- Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke PatientsStroke, 2001
- Oxidative Stress in the Context of Acute Cerebrovascular StrokeStroke, 2000
- Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic StrokeStroke, 2000
- Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British menThe Lancet, 1995
- Plasma Homocysteine in the Acute and Convalescent Phases After StrokeStroke, 1995
- A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.Stroke, 1994
- A prospective study on hip fractures in patients with previous cerebrovascular accidentsInjury, 1992
- Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjectsAtherosclerosis, 1989
- Hip fracture after hemiplegiaPostgraduate Medical Journal, 1979